Michael Morton

Michael Morton

Principal Scientist II
Regulatory Sciences

Michael Morton, Ph.D., is a Principal Scientist II in Strategy, Engagement & Insights in the Regulatory Sciences department at Altria Client Services in Richmond, VA. In this role, he provides statistical analysis and expertise in support of regulatory filings with FDA and external scientific engagement.

Dr. Morton is actively involved within the Cooperation Centre for Scientific Research Relative to Tobacco (CORESTA) and the International Organization for Standardization (ISO) to develop robust consensus standardized methods for the analysis of harmful and potentially harmful constituents in tobacco products.  In CORESTA, Dr. Morton serves on several subgroups and task forces providing statistical analysis expertise and guidance. He is an international expert to ISO Technical Committee 69 (TC 69) on the application of statistical methods, primarily focused  on measurement uncertainty, including the statistical analysis of interlaboratory studies.  Dr. Morton is also involved in ISO Technical Committee 126 on Tobacco and Tobacco Products.

Dr. Morton has authored 40 articles in peer-reviewed publications and regularly shares his work at scientific conferences.  Prior to this current role, he has served in numerous other areas, including analytical chemistry, clinical evaluation, toxicological testing, manufacturing, sensory evaluation, consumer testing, regulatory reporting, tobacco processing, leaf purchasing, and quality control.

PhD, Statistics, Southern Methodist University, Dallas, Texas, 1981

MA, Mathematics, University of Texas, Austin, Texas, 1978

BS, Chemistry, Salem College, Winston-Salem, North Carolina, 1993

BA, Mathematics, University of Texas, Austin, Texas, 1976